| Synonyms: | |
| Status: | Approved |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | A16AA02 |
| UNII: | 7LP2MPO46S |
| InChI Key | MEFKEPWMEQBLKI-AIRLBKTGSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C15H22N6O5S |
| Molecular Weight | 398.45 |
| AlogP | -3.26 |
| Hydrogen Bond Acceptor | 11.0 |
| Hydrogen Bond Donor | 4.0 |
| Number of Rotational Bond | 7.0 |
| Polar Surface Area | 185.46 |
| Molecular species | ZWITTERION |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 27.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Lyase
|
- | - | - | 60000 | - | |
|
Enzyme
Transferase
|
- | - | 4800-11000 | - | - | |
|
Enzyme
|
- | - | 4800-11000 | 48000 | - | |
|
Epigenetic regulator
Writer
Protein methyltransferase
Protein arginine methyltransferase
|
- | 12000 | - | - | - | |
|
Unclassified protein
|
17 | - | 4 | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Non-alcoholic Fatty Liver Disease | 3 | D065626 | ClinicalTrials |
| Cholestasis, Intrahepatic | 3 | D002780 | ClinicalTrials |
| Liver Cirrhosis, Biliary | 2 | D008105 | ClinicalTrials |
| Depressive Disorder, Major | 2 | D003865 | ClinicalTrials |
| Depressive Disorder | 2 | D003866 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 67040 |
| ChEMBL | CHEMBL1088977 |
| DrugBank | DB00118 |
| DrugCentral | 2414 |
| EPA CompTox | DTXSID6032019 |
| FDA SRS | 7LP2MPO46S |
| KEGG | C00019 |
| PubChem | 34756 |
| SureChEMBL | SCHEMBL1300198 |